Pragmatic clinical trials in the context of regulation of medicines

References

• Friedman LM, Furberg CD, DeMets DL. Fundamentals of clinical trials. Heidelberg: Springer International Publishing; 2015.
   Google Scholar
• Sherman RE, Anderson SA, Dal Pan GJ, Gray GW, Gross T, Hunter NL, et al. Real-world evidence - what is it and what can it tell us? N Engl J Med. 2016;375:2293–7.
   PubMed Web of Science ®Google Scholar
• Loudon K, Treweek S, Sullivan F, Donnan P, Thorpe KE, Zwarenstein M. The PRECIS-2 tool: designing trials that are fit for purpose. BMJ. 2015;350:h2147.
   PubMed Web of Science ®Google Scholar
• Ford I, Norrie J. Pragmatic trials. N Engl J Med. 2016;375:454–63.
   PubMed Web of Science ®Google Scholar
• Weinfurt KP, Hernandez AF, Coronado GD, DeBar LL, Dember LM, Green BB, et al. Pragmatic clinical trials embedded in healthcare systems: generalizable lessons from the NIH Collaboratory. BMC Med Res Methodol. 2017;17:144.
   PubMed Web of Science ®Google Scholar
• International conference on harmonisation of technical requirements for registration of pharmaceuticals for human use. Guideline for good clinical practice E6 (R2). London: European Medicines Agency; 2016.
   Google Scholar
• The European Parliament and the Council of the European Union. Regulation (EU) No 536/2014 of the European Parliament and of the Council of 16 April 2014 on clinical trials on medicinal products for human use, and repealing Directive 2001/20/EC 2014.
   Google Scholar
• Evans SJW, Leufkens HGM. Regulatory decision-making: are we getting it right? Pharmacoepidemiol Drug Saf. 2014;23:1012–16.
   PubMed Web of Science ®Google Scholar
• Hatswell AJ, Baio G, Berlin JA, Irs A, Freemantle N. Regulatory approval of pharmaceuticals without a randomised controlled study: analysis of EMA and FDA approvals 1999-2014. BMJ Open. 2016;6:e011666.
   PubMed Web of Science ®Google Scholar
• European Medicines Agency. Conditional marketing authorisation. London, UK: European Medicines Agency; 2017.
   Google Scholar
• Feltelius N, Gedeborg R, Holm L, Zethelius B. Utility of registries for post-marketing evaluation of medicines. A survey of Swedish health care quality registries from a regulatory perspective. Ups J Med Sci. 2017;122:136–47.
   PubMed Web of Science ®Google Scholar
• Ludvigsson JF, Andersson E, Ekbom A, Feychting M, Kim JL, Reuterwall C, et al. External review and validation of the Swedish national inpatient register. BMC Public Health. 2011;11:450.
   PubMed Web of Science ®Google Scholar
• Herrett E, Thomas SL, Schoonen WM, Smeeth L, Hall AJ. Validation and validity of diagnoses in the General Practice Research Database: a systematic review. Br J Clin Pharmacol. 2010;69:4–14.
   PubMed Web of Science ®Google Scholar
• Ludvigsson JF, Otterblad-Olausson P, Pettersson BU, Ekbom A. The Swedish personal identity number: possibilities and pitfalls in healthcare and medical research. Eur J Epidemiol. 2009;24:659–67.
   PubMed Web of Science ®Google Scholar
• Heim N, van Stel HF, Ettema RG, van der Mast RC, Inouye SK, Schuurmans MJ. HELP! Problems in executing a pragmatic, randomized, stepped wedge trial on the Hospital Elder Life Program to prevent delirium in older patients. Trials. 2017;18:220.
   PubMed Web of Science ®Google Scholar
• LaVange LM, Permutt T. A regulatory perspective on missing data in the aftermath of the NRC report. Stat Med. 2016;35:2853–64.
   PubMed Web of Science ®Google Scholar
• Committee for Human Medicinal Products. ICH E9 (R1) addendum on estimands and sensitivity analysis in clinical trials to the guideline on statistical principles for clinical trials. London, UK: European Medicines Agency; 2017.
   Google Scholar
• Gedeborg R, Furebring M, Michaelsson K. Diagnosis-dependent misclassification of infections using administrative data variably affected incidence and mortality estimates in ICU patients. J Clin Epidemiol. 2007;60:155–62.
   PubMed Web of Science ®Google Scholar
• James S, Rao SV, Granger CB. Registry-based randomized clinical trials–a new clinical trial paradigm. Nat Rev Cardiol. 2015;12:312–16.
   PubMed Web of Science ®Google Scholar
• Rothman K, Greenland S, Lash T. Validity in epidemiological studies. Modern epidemiology. 3rd ed. Philadelphia: Lippincott Williams & Wilkins; 2008. p. 128–47.
   Google Scholar
• Committee for Medicinal Products for Human Use (CHMP) European Medicines Agency. Guideline on the investigation of subgroups in confirmatory clinical trials (draft). London, UK: European Medicines Agency; 2014. EMA/CHMP/539146/2013.
   Google Scholar
• Ioannidis J, Lau J. Evolution of treatment effects over time: empirical insight from recursive cumulative metaanalyses. Proc Natl Acad Sci U S A. 2001;98:831–6.
   PubMed Web of Science ®Google Scholar
• European Medicines Agency. Reflection paper on the use of extrapolation in the development of medicines for paediatrics (draft). London, UK: European Medicines Agency, 2017. EMA/199678/2016.
   Google Scholar
• Bourgeois FT, Olson KL, Tse T, Ioannidis JP, Mandl KD. Prevalence and characteristics of interventional trials conducted exclusively in elderly persons: a cross-sectional analysis of registered clinical trials. PLoS One. 2016;11:e0155948.
   PubMed Web of Science ®Google Scholar
• European Medicines Agency. Assessment report for solutions for infusion containing hydroxyethyl starch (EMA/667674/2013). London, UK: European Medicines Agency; 2013. Contract No.: EMA/667674/2013.
   Google Scholar
• Perner A, Haase N, Guttormsen AB, Tenhunen J, Klemenzson G, Aneman A, et al. Hydroxyethyl starch 130/0.42 versus Ringer's acetate in severe sepsis. N Engl J Med. 2012;367:124–34.
   PubMed Web of Science ®Google Scholar
• Myburgh JA, Finfer S, Bellomo R, Billot L, Cass A, Gattas D, et al. Hydroxyethyl starch or saline for fluid resuscitation in intensive care. N Engl J Med. 2012;367:1901–11.
   PubMed Web of Science ®Google Scholar
• Chappell D, Jacob M. Hydroxyethyl starch - the importance of being earnest. Scand J Trauma Resusc Emerg Med. 2013;21:61.
   PubMed Web of Science ®Google Scholar
• Ioannidis JP, Lau J. Completeness of safety reporting in randomized trials: an evaluation of 7 medical areas. JAMA. 2001;285:437–43.
   PubMed Web of Science ®Google Scholar